Rating History for Horizon Therapeutics (HZNP) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/22/2021 | David Risinger | New Coverage | Overweight (N/A) |
103.00 (N/A) |
88.15 (116.30) |
31.93% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
